BELLANDO RANDONE, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.971
EU - Europa 9.966
AS - Asia 7.727
SA - Sud America 1.064
AF - Africa 211
OC - Oceania 113
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.059
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.791
RU - Federazione Russa 3.106
IT - Italia 2.900
SG - Singapore 2.145
CN - Cina 2.107
PL - Polonia 1.425
HK - Hong Kong 1.089
BR - Brasile 830
VN - Vietnam 751
KR - Corea 675
IE - Irlanda 593
SE - Svezia 389
FR - Francia 342
FI - Finlandia 320
IN - India 306
DE - Germania 251
NL - Olanda 187
GB - Regno Unito 160
JP - Giappone 109
AU - Australia 107
ID - Indonesia 106
CA - Canada 95
JO - Giordania 93
AR - Argentina 92
ES - Italia 72
CH - Svizzera 67
BD - Bangladesh 65
MX - Messico 51
IQ - Iraq 49
TR - Turchia 45
CI - Costa d'Avorio 42
ZA - Sudafrica 38
UA - Ucraina 35
EC - Ecuador 33
MA - Marocco 27
CO - Colombia 25
NG - Nigeria 23
PH - Filippine 22
VE - Venezuela 22
PK - Pakistan 21
EG - Egitto 19
PY - Paraguay 17
AT - Austria 15
BJ - Benin 15
PE - Perù 14
UY - Uruguay 14
AZ - Azerbaigian 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
LT - Lituania 12
TN - Tunisia 12
CL - Cile 11
KZ - Kazakistan 11
JM - Giamaica 10
KE - Kenya 10
MY - Malesia 10
RO - Romania 10
AE - Emirati Arabi Uniti 9
RS - Serbia 9
BE - Belgio 8
IL - Israele 8
LV - Lettonia 8
IR - Iran 7
LB - Libano 7
NP - Nepal 7
AL - Albania 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
EU - Europa 6
GE - Georgia 6
OM - Oman 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
DK - Danimarca 5
HU - Ungheria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PA - Panama 5
TH - Thailandia 5
TW - Taiwan 5
BH - Bahrain 4
CR - Costa Rica 4
DZ - Algeria 4
KG - Kirghizistan 4
BY - Bielorussia 3
KH - Cambogia 3
KW - Kuwait 3
PT - Portogallo 3
SN - Senegal 3
SY - Repubblica araba siriana 3
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
MC - Monaco 2
MD - Moldavia 2
MK - Macedonia 2
Totale 31.027
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.500
Ashburn 1.653
Singapore 1.591
Warsaw 1.411
Fairfield 961
Hong Kong 938
Seoul 668
Hefei 589
Dublin 583
Chandler 495
Woodbridge 473
San Jose 440
Seattle 401
Florence 398
Beijing 371
Houston 367
Cambridge 356
Wilmington 300
Ho Chi Minh City 245
Milan 221
Lawrence 206
Rome 204
Altamura 193
Lauterbourg 189
Moscow 178
Los Angeles 177
Princeton 165
Helsinki 157
Ann Arbor 156
Hanoi 154
Buffalo 143
Mumbai 142
The Dalles 141
Boston 127
Council Bluffs 127
Munich 102
Tokyo 101
Melbourne 99
New York 97
Kent 86
Shanghai 82
São Paulo 78
Jakarta 76
Naples 73
Paris 69
Dallas 64
San Diego 58
Boardman 57
Turku 56
Turin 55
Pune 51
Bologna 49
Bern 47
Clifton 47
Chicago 45
Abidjan 42
Dong Ket 42
Medford 42
Montreal 42
Falls Church 39
Redondo Beach 38
London 37
Orem 36
Bengaluru 34
Lappeenranta 34
Zeist 32
Da Nang 30
Bari 29
Catania 28
Frankfurt am Main 28
Phoenix 28
Rio de Janeiro 28
Johannesburg 27
Norwalk 27
Guangzhou 26
Yubileyny 26
Barcelona 25
Jacksonville 25
Chennai 24
Abuja 23
Brooklyn 23
Tianjin 22
Toronto 22
Haiphong 21
Belo Horizonte 20
Cagliari 20
West Jordan 20
Mexico City 19
Atlanta 18
Baghdad 18
Denver 17
Salt Lake City 17
Genoa 16
Hillsboro 16
Padova 16
Reggio Emilia 16
Shenzhen 16
Cotonou 15
Nuremberg 15
Andover 14
Totale 19.965
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 1.800
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 364
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 351
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 331
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 320
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 303
Interstitial lung disease in systemic sclerosis: Where do we stand? 280
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 280
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 272
Very Early Diagnosis of Systemic Sclerosis (Diagnosi molto precoce della Sclerosi Sistemica) VEDOSS, 2010-2015 (2020). Validazione dei segni e sintomi in uno studio prospettico osservazionale di coorte 272
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 262
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 257
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 241
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 241
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 239
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 236
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 226
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 221
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 211
A rare case of Candida glabrata spondylodiscitis: case report and literature review 206
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 203
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 203
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 201
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 197
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 197
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 196
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 194
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 193
STRATEGIE PER IMPLEMENTARE NEL CONTESTO ITALIANO LE “RECOMMENDATIONS FOR THE IMPLEMENTATION OF SELF-MANAGEMENT STRATEGIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS” DI EULAR (2021) 192
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 190
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 189
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 188
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 188
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 186
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 185
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 184
Calcinosis in systemic sclerosis: subsets, distribution and complications 183
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 182
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 181
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 181
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 176
Systemic Sclerosis Association with Malignancy 175
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 174
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 173
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 173
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 173
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 171
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 170
Treatment options in systemic sclerosis 170
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 168
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 168
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 167
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 167
The safety of iloprost in systemic sclerosis in a real-life experience 166
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 165
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 165
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 165
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 164
Antioxidant agents help primary Raynaud's phenomenon 163
Transitional connective tissue diseases: description of four cases 162
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 161
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 161
Persistence of remission after lengthening of golimumab in inflammatory joint diseases 160
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 160
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 160
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 159
Digital ulcers predict a worse disease course in patients with systemic sclerosis 158
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 156
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 155
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 153
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 153
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 153
The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis 150
Effects of rituximab in connective tissue disorders related interstitial lung disease 150
GASTROINTESTINAL INVOLVEMENT AND QUALITY OF LIFE IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 149
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 148
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort 148
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 148
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 147
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 147
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 147
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 146
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 146
Oral lactobacillus species in systemic sclerosis 145
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 145
Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests 144
Prognostic value of lung ultrasound B-lines in systemic sclerosis 144
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life 143
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 143
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 142
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 142
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 142
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 142
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 141
The role of the dermatologist in Raynaud's Phenomenon: a clinical challenge 141
Mycosis fungoides: from early stages to fatal central nervous system involvement 141
Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience 141
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 140
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 139
Systemic sclerosis and infections. 138
Totale 20.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 99 76
2021/2022959 19 69 94 35 49 65 26 97 68 34 122 281
2022/20232.568 278 566 105 142 134 409 364 110 224 43 102 91
2023/20242.015 45 148 228 113 122 235 128 343 80 249 191 133
2024/20259.798 360 974 569 1.500 2.310 1.085 430 742 475 351 462 540
2025/202610.818 1.282 1.610 1.254 1.170 1.460 429 1.327 598 813 701 174 0
Totale 31.430